Fatma Feriha ÇİLLİ, Alper TÜNGER, Sabire Şöhret AYDEMİR, Hilal SİPAHİ, Bilgin ARDA, Serhat UYSAL, Meltem TAŞBAKAN, Oğuz Reşat SİPAHİ, Hüsnü PULLUKÇU, Sercan ULUSOY, Tansu YAMAZHAN

Antibacterial resistance patterns and incidence of hospital-acquired Staphylococcus aureus bacteremia in a tertiary care educational hospital in Turkey: a perspective from 2001 to 2013

Background/aim: Staphylococcus aureus is an important nosocomial pathogen and a successful antimicrobial-resistance developer. In this study we retrospectively evaluated the resistance patterns and incidence of microbiologically confirmed nosocomial bacteremia (MCNB) related S. aureus strains between 2001 and 2013. Materials and methods: Any patient in whom S. aureus was isolated in at least one set of blood cultures (sent to the bacteriology laboratory 72 h after hospital admission) was considered to have MCNB. Results: The methicillin-resistant S. aureus (MRSA) rate in 2001 was 73.8% whereas it was 36.2% in 2013. When the 2001 2003 and 2011 2013 periods were compared, resistance to oxacillin, levofloxacin, gentamicin, erythromycin, and clindamycin decreased significantly (P < 0.05). When we evaluated the total S. aureus, MRSA, and methicillin-sensitive S. aureus (MSSA) bacteremia rates per 1000 days and 1000 patients, there was an increase in the 2004 2005 period, which was followed by a slight decrease until 2013 (P < 0.05). There was a plateau in MCNB-related S. aureus rates between 2008 and 2011. Conclusion: There was a decrease in overall S. aureus and MRSA bacteremia incidence as well as MRSA rates except for a plateau between 2008 and 2011. This steady decrease in the resistance rates is most probably due to the 2003 budget application and application of antimicrobial stewardship.

PDF

___

1. Sipahi OR. Economics of antibiotic resistance. Expert Rev Anti Infect Ther 2008; 6: 523-539.
2. Erdem H, Dizbay M, Karabey S, Kaya S, Demirdal T, Koksal I, Inan A, Erayman I, Ak O, Ulu-Kilic A et al. Withdrawal of Staphylococcus aureus from intensive care units in Turkey. Am J Infect Control 2013; 41: 1053-1058.
3. Yüce ZT, Alp E. Infection control bundles for the prevention of hospital infections. Mediterr J Infect Microb Antimicrob 2016; 5: 8.
4. Aksoy F, Kenç NN, Yılmaz G, Bayramoğlu G, Köksal İ. Hastane kaynaklı Staphylococcus aureusun etken olduğu kan dolaşımı enfeksiyonlarının değerlendirilmesi. Mediterr J Infect Microb Antimicrob 2016; 5 (suppl 1): 23 (in Turkish).
5. Şencan İ, Kalaycı MZ, Kabasakal E, Oku FC, Şardan YÇ, Aşçıoğlu S. 2012 UHESA Report: National Nosocomial Infections Surveillance Network Report. In: Proceedings of the National Nosocomial Infections Surveillance Network Report 2012; Ankara. Ministry of Health of the Republic of Turkey General Directorate of Health Services; 2013.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 21st informational supplement. CLSI document 2011; M100-S21.
7. Gould FK, Brindle R, Chadwick PR, Fraise AP, Hill S, Nathwani D, Ridgway GL, Spry MJ, Warren RE. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother 2009; 63: 849-861.
8. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016; 62: 13.
9. Arda B, Sipahi OR, Yamazhan T, Tasbakan M, Pullukcu H, Tunger A, Buke C, Ulusoy S. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. J Infect 2007; 55: 41-48.
10. Tunger O, Karakaya Y, Cetin CB, Dinc G, Borand H. Rational antibiotic use. J Infect Dev Ctries 2009; 3: 88-93.
11. Ozkurt Z, Erol S, Kadanali A, Ertek M, Ozden K, Tasyaran MA. Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists. Jpn J Infect Dis 2005; 58: 338-343.
12. Arda B, Şenol Ş, Taşbakan MI, Yamazhan T, Sipahi OR, Arsu G, Ulusoy S. Evaluation of compliance with hand hygiene rules in Ege University Medical Faculty Intensive Care Units. Turkish Journal of Intensive Care Medicine 2005; 5: 182-186.
13. Sipahi OR, Arda B, Bayram A, Aydemir S, Turhan T, Çilli F, Sipahi H, Ulusoy S. Effect of search-and-destroy policy on Staphylococcus aureus bacteraemia and overall methicillinresistant S. aureus rates: experience from neurosurgery clinic of a tertiary-care educational university hospital with endemic MRSA. In: Proceedings of the 20th European Congress of Clinical Microbiology and Infectious Diseases; Vienna, Austria. ECCMID; 2010. pp. 446.